Koninklijke Philips (PHG) Total Non-Current Liabilities (2009 - 2026)
Koninklijke Philips (PHG) recorded quarterly Total Non-Current Liabilities of $9.9 billion in Q1 2026, little changed quarter-over-quarter from $9.8 billion in Q4 2025, and up 7.89% on a YoY basis from $9.1 billion in Q1 2025.
Koninklijke Philips (PHG) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $9.9 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 7.89% year-over-year to $9.9 billion; the TTM figure through Mar 2026 stood at $9.9 billion (up 7.89% YoY), while the FY2025 annual figure was $9.8 billion, up 4.7% from the prior year.
- Total Non-Current Liabilities was $9.9 billion for Q1 2026 at Koninklijke Philips, roughly flat from $9.8 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $10.2 billion in Q3 2025 to a low of $9.1 billion in Q1 2025.
- Historically, Total Non-Current Liabilities has averaged $9.7 billion across 5 years, with a median of $9.8 billion in 2025.
- The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities decreased 6.53% in 2022, then climbed 7.89% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $9.7 billion in 2022, then grew by 0.86% to $9.7 billion in 2023, then decreased by 3.65% to $9.4 billion in 2024, then advanced by 4.7% to $9.8 billion in 2025, then grew by 0.23% to $9.9 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $9.9 billion (Q1 2026), $9.8 billion (Q4 2025), and $10.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 9.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.85 Bn |
| Dec 31, 2025 | 9.83 Bn |
| Sep 30, 2025 | 10.20 Bn |
| Jun 30, 2025 | 9.93 Bn |
| Mar 31, 2025 | 9.13 Bn |
| Dec 31, 2024 | 9.39 Bn |
| Jun 30, 2024 | 9.47 Bn |
| Dec 31, 2023 | 9.75 Bn |
| Jun 30, 2023 | 10.10 Bn |
| Dec 31, 2022 | 9.66 Bn |
| Jun 30, 2022 | 9.92 Bn |
| Dec 31, 2021 | 10.34 Bn |
| Jun 30, 2021 | 9.93 Bn |
| Dec 31, 2020 | 9.63 Bn |
| Jun 30, 2020 | 9.93 Bn |
| Dec 31, 2019 | 8.21 Bn |
| Jun 30, 2019 | 8.19 Bn |
| Dec 31, 2018 | 6.80 Bn |
| Jun 30, 2018 | 7.16 Bn |
| Dec 31, 2017 | 7.57 Bn |